Cornell University Veterinary Specialists 24 Hour Emergency and Critical Care

Dr. Gerald Post

Dr. Gerald Post

Gerald Post, DVM, DACVIM (Oncology), MEM

EDUCATION

University of Minnesota, DVM, 1988

Duke University, MEM, 2010

SPECIALTY TRAINING

Animal Medical Center, NYC, Residency in Oncology, 1991

SPECIALTY CERTIFICATION

Diplomate of the American College of Veterinary Internal Medicine, 1992

Dr. Gerald Post is one of approximately two hundred board-certified veterinary oncologists in the United States. Dr. Post graduated with distinction from Cornell University in 1983 and received his DVM degree from the University of Minnesota in 1988. In 1991, he completed a residency in Oncology at the Animal Medical Center in New York and in 1992 became a Diplomate of the American College of Veterinary Internal Medicine. In 2010, he obtained a Master's degree in Environmental Management from Duke University. Dr. Post has authored many papers and book chapters on the topics of oncology and hematology and has been recognized by New York magazine as one of the best veterinarians in the Tri-State area. Recently Dr. Post and colleagues have authored two seminal papers significantly advancing the treatment of both B-cell lymphoma and T-cell lymphoma in dogs. Dr. Post has devoted his life to animals and has always had a strong interest in small animal oncology.

Specialty Services

Oncology

Selected Publications

  • Barry Smith, Lawrence Gazda, Bryan Conn, Kanti Jain, Shirin Asina, Daniel Levine, Thomas Parker, Melissa Laramore, Prithy Martis, Horatiu Vinerean, Eric David, Suizhen Qiu, C. Guillermo Cuoto, Gerald Post, David Waters, Carlos Cordon-Cardo, Richard Hall, Bruce Gordon, Carolyn Diehl, Kurt Stenzel, and Albert Rubin Novel Tumor Growth-Control by a Subpopulation of Mouse Renal Carcinoma Cells Isolated and Maintained in Hydrophilic Agarose Macrobeads. Cancer Research (in press)
  • A. T. Daters, G. E. Mauldin, G. N. Mauldin, E. M. Brodsky, G. S. Post Evaluation of a Multidrug Chemotherapy Protocol with Mitoxantrone- based Maintenance (CHOP-MA) for the Treatment of Canine Lymphoma. Journal of Veterinary and Comparative Oncology. 2010, March: 8 (1):11-22
  • Brodsky EM, Mauldin GN, Lachowicz JL, and Post GP. Asparaginase and MOPP Treatment of Dogs with Lymphoma. Journal of Veterinary Internal Medicine. 2009 May-Jun:23(3):578-584
  • Lachowicz JL, Post GS, Brodsky E. A Phase I Clinical Trial Evaluating Imatinib Mesylate (Gleevec) in Tumor-Bearing Cats. Journal of Veterinary Internal Medicine. 2005 Nov-Dec;19(6):860-4.
  • Lachowicz JL, Post GS, Moroff SD, Mooney SC. Acquired Amegakaryocytic Thrombocytopenia--Four Cases and a Literature Review. Journal of Small Animal Practice. 2004 Oct;45(10):507-14.
  • London CA, Hannah AL, Zadovoskaya R, Chien MB, Kollias-Baker C, Rosenberg M, Downing S, Post G, Boucher J, Shenoy N, Mendel DB, McMahon G, Cherrington JM. Phase I Dose-escalating Study of SU11654, a Small Molecule Receptor Tyrosine Kinase Inhibitor, in Dogs with Spontaneous Malignancies. Clinical Cancer Research. 2003 Jul;9(7):2755-68

Information

Cornell University Veterinary Specialists
880 Canal Street
Stamford, CT 06902
Phone 203.595.2777   Fax 203.595.2778

Emergency Hours

24 Hours a day, 7 days a week

Emergency & Critical Care Information

Specialty Hours

Monday - Friday

9am to 6pm

Weekend hours available by special appointment